Solasia Pharma K.K. 4597Short Interest
Estimated short interest in Solasia Pharma K.K. (4597) is 6.86% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: Barclays Capital Securities Ltd, GOLDMAN SACHS INTERNATIONAL, Individual and 2 others.
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It excludes 4 institutions whose last report is more than a year old (3.20% in total). It also excludes 20 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2017-08-29 |
|---|---|
| Latest disclosure | 2026-11-16 (Barclays Capital Securities Ltd, 2.74%) |
| Reporting institutions | 29 firms (2626 reports) |
| Peak estimated short interest | 17.38% (2024-09-25, 11 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Barclays Capital Securities Ltd
- GOLDMAN SACHS INTERNATIONAL
- Individual
- Arrowstreet Capital, Limited Partnership
- Squarepoint Operations Private Limited
- Others
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-11-16 | Barclays Capital Securities Ltd | Position 7,511,149 shares | Ratio 2.74% | ▲0.15% | Holding |
| 2026-11-10 | GOLDMAN SACHS INTERNATIONAL | Position 4,358,848 shares | Ratio 1.59% | ▲0.19% | Holding |
| 2017-11-02 | JPMorgan Securities Japan Co., Ltd. | Position 1,160,900 shares | Ratio 1.32% | ▲0.22% | No report for 1+ year |
| 2026-10-13 | Individual | Position 3,000,000 shares | Ratio 1.09% | ▲0.18% | Holding |
| 2024-07-24 | Arrowstreet Capital ESG Global Equity Long/Short Fund Limited | Position 1,676,000 shares | Ratio 0.77% | ▲0.18% | No report for 1+ year |
| 2026-05-19 | Arrowstreet Capital, Limited Partnership | Position 2,110,100 shares | Ratio 0.77% | ▲0.18% | Holding |
| 2026-11-16 | Squarepoint Operations Private Limited | Position 1,855,600 shares | Ratio 0.67% | ▲0.34% | Holding |
| 2024-07-03 | Arrowstreet ACWI Alpha Extension Fund V (Cayman) Limited | Position 1,196,900 shares | Ratio 0.59% | ▼0.10% | No report for 1+ year |
| 2024-07-29 | Susquehanna Pacific Pty Ltd | Position 465,500 shares | Ratio 0.52% | ▲0.31% | No report for 1+ year |
| 2025-05-01 | ActusRayPartners Limited | Position 1,092,972 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-08-10 | Citigroup Global Markets Limited | Position 1,358,100 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2019-05-16 | Deutsche Bank Aktiengesellschaft, London | Position 510,600 shares | Ratio 0.48% | ▼0.03% | Below 0.5% |
| 2024-07-18 | BNP Paribas Financial Markets SNC formerly known as BNP Paribas Arbitrage SNC | Position 1,052,500 shares | Ratio 0.48% | ▼0.11% | Below 0.5% |
| 2024-09-24 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 1,039,000 shares | Ratio 0.47% | ▼0.03% | Below 0.5% |
| 2025-07-09 | BNP Paribas Financial Markets SNC | Position 1,182,200 shares | Ratio 0.47% | ▼0.03% | Below 0.5% |
| 2026-07-10 | GOLDMAN SACHS JAPAN CO., LTD. | Position 1,238,200 shares | Ratio 0.45% | ▼0.32% | Below 0.5% |
| 2019-11-29 | Credit Suisse Securities (Europe) Limited | Position 460,500 shares | Ratio 0.43% | ▼0.09% | Below 0.5% |
| 2019-12-03 | Credit Suisse Securities (Japan) Limited | Position 448,700 shares | Ratio 0.42% | ▼0.08% | Below 0.5% |
| 2026-07-31 | Nomura International plc | Position 1,068,100 shares | Ratio 0.39% | ▼0.41% | Below 0.5% |
| 2026-03-10 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,032,339 shares | Ratio 0.38% | ▼0.21% | Below 0.5% |
| 2026-06-09 | Squarepoint Ops LLC | Position 931,300 shares | Ratio 0.34% | ▼0.51% | Below 0.5% |
| 2022-10-19 | Credit Suisse AG | Position 552,301 shares | Ratio 0.32% | ▼0.65% | Below 0.5% |
| 2026-10-19 | Morgan Stanley & Co. International plc | Position 897,300 shares | Ratio 0.32% | ▼0.20% | Below 0.5% |
| 2026-11-10 | JPM Securities Japan Co Ltd. | Position 866,620 shares | Ratio 0.31% | ▼0.19% | Below 0.5% |
| 2025-03-25 | MERRILL LYNCH INTERNATIONAL | Position 653,949 shares | Ratio 0.29% | ▼0.34% | Below 0.5% |
| 2025-07-04 | UBS AG | Position 454,800 shares | Ratio 0.18% | ▼0.36% | Below 0.5% |
| 2018-01-31 | JANE STREET GLOBAL TRADING, LLC | Position 101,600 shares | Ratio 0.11% | ▼0.57% | Below 0.5% |
| 2025-03-03 | XTX Markets Pte Ltd | Position 144,800 shares | Ratio 0.06% | ▼0.45% | Below 0.5% |
| 2026-01-08 | Macquarie Bank Limited | Position 37,300 shares | Ratio 0.01% | ▼0.89% | Below 0.5% |
Disclosure History 2626 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-16 | Squarepoint Operations Private Limited | Position 1,855,600 shares | Ratio 0.67% | ▲0.34% | — |
| 2026-11-16 | Barclays Capital Securities Ltd | Position 7,511,149 shares | Ratio 2.74% | ▲0.15% | — |
| 2026-11-13 | Barclays Capital Securities Ltd | Position 7,103,749 shares | Ratio 2.59% | ▼0.04% | — |
| 2026-11-12 | Barclays Capital Securities Ltd | Position 7,207,149 shares | Ratio 2.63% | ▼0.08% | — |
| 2026-11-11 | Barclays Capital Securities Ltd | Position 7,410,449 shares | Ratio 2.71% | ▼0.11% | — |
| 2026-11-10 | JPM Securities Japan Co Ltd. | Position 866,620 shares | Ratio 0.31% | ▼0.19% | Below 0.5% |
| 2026-11-10 | GOLDMAN SACHS INTERNATIONAL | Position 4,358,848 shares | Ratio 1.59% | ▲0.19% | — |
| 2026-11-10 | Barclays Capital Securities Ltd | Position 7,737,549 shares | Ratio 2.82% | ▲0.11% | — |
| 2026-11-09 | JPM Securities Japan Co Ltd. | Position 1,379,020 shares | Ratio 0.50% | ▼0.12% | — |
| 2026-11-09 | GOLDMAN SACHS INTERNATIONAL | Position 3,851,148 shares | Ratio 1.40% | ▲0.04% | — |
| 2026-11-09 | Barclays Capital Securities Ltd | Position 7,436,149 shares | Ratio 2.71% | ▲0.76% | — |
| 2026-11-06 | JPM Securities Japan Co Ltd. | Position 1,712,720 shares | Ratio 0.62% | ▼0.25% | — |
| 2026-11-06 | GOLDMAN SACHS INTERNATIONAL | Position 3,719,548 shares | Ratio 1.36% | ▲0.22% | — |
| 2026-11-06 | Barclays Capital Securities Ltd | Position 5,336,949 shares | Ratio 1.95% | ▲0.46% | — |
| 2026-11-05 | JPM Securities Japan Co Ltd. | Position 2,388,620 shares | Ratio 0.87% | ▼0.26% | — |
| 2026-11-05 | Barclays Capital Securities Ltd | Position 4,098,449 shares | Ratio 1.49% | ▲0.28% | — |
| 2026-11-04 | JPM Securities Japan Co Ltd. | Position 3,100,820 shares | Ratio 1.13% | ▼0.12% | — |
| 2026-11-04 | GOLDMAN SACHS INTERNATIONAL | Position 3,135,548 shares | Ratio 1.14% | ▼0.12% | — |
| 2026-11-04 | Barclays Capital Securities Ltd | Position 3,330,849 shares | Ratio 1.21% | ▲0.14% | — |
| 2026-11-02 | JPM Securities Japan Co Ltd. | Position 3,432,720 shares | Ratio 1.25% | ▼0.14% | — |
| 2026-11-02 | Barclays Capital Securities Ltd | Position 2,946,649 shares | Ratio 1.07% | ▲0.15% | — |
| 2026-10-30 | GOLDMAN SACHS INTERNATIONAL | Position 3,468,548 shares | Ratio 1.26% | ▼0.09% | — |
| 2026-10-30 | Barclays Capital Securities Ltd | Position 2,532,049 shares | Ratio 0.92% | ▲0.12% | — |
| 2026-10-29 | GOLDMAN SACHS INTERNATIONAL | Position 3,698,048 shares | Ratio 1.35% | ▼0.08% | — |
| 2026-10-28 | Barclays Capital Securities Ltd | Position 2,213,749 shares | Ratio 0.80% | ▲0.05% | — |
| 2026-10-27 | GOLDMAN SACHS INTERNATIONAL | Position 3,919,648 shares | Ratio 1.43% | ▼0.11% | — |
| 2026-10-23 | Barclays Capital Securities Ltd | Position 2,051,049 shares | Ratio 0.75% | ▼0.09% | — |
| 2026-10-22 | JPM Securities Japan Co Ltd. | Position 3,814,820 shares | Ratio 1.39% | ▼0.04% | — |
| 2026-10-22 | GOLDMAN SACHS INTERNATIONAL | Position 4,220,348 shares | Ratio 1.54% | ▲0.13% | — |
| 2026-10-22 | Barclays Capital Securities Ltd | Position 2,312,949 shares | Ratio 0.84% | ▼0.97% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| SanBio Company Limited4592 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| HEALIOS K.K.4593 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| BrightPath Biotherapeutics Co.,Ltd.4594 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| MIZUHO MEDY CO.,LTD.4595 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kubota Pharmaceutical Holdings Co.,Ltd.4596 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Delta-Fly Pharma,Inc.4598 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| StemRIM Inc.4599 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| MediciNova,Inc.4875 | Standard Market(Foreign) | Pharmaceutical | Pharmaceutical | |
| CellSource Co.,Ltd.4880 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| FunPep Company Limited4881 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |